UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Incidence of Anxiety in Parkinson's Disease During the Coronavirus Disease (COVID‐19) Pandemic

Movement disorders, 2020-07, Vol.35 (7), p.1095-1096

2020

Volltextzugriff (PDF)

Significant modulations of linc001128 and linc0938 with miR-24-3p and miR-30c-5p in Parkinson disease

Scientific reports, 2022-02, Vol.12 (1), p.2569-2569, Article 2569

2022

Volltextzugriff (PDF)

Immunomodulatory drug fingolimod (FTY720) restricts the growth of opportunistic yeast Candida albicans in vitro and in a mouse candidiasis model

PloS one, 2022-12, Vol.17 (12), p.e0278488-e0278488

2022

Volltextzugriff (PDF)

Immunomodulatory drug fingolimod (FTY720) restricts the growth of opportunistic yeast Candida albicans in vitro and in a mouse candidiasis model

PloS one, 2022-12, Vol.17 (12), p.e0278488

2022

Volltextzugriff (PDF)

Span of spleen is associated with disability status in multiple sclerosis: a cross-sectional abdominopelvic ultrasonography study

Scientific reports, 2024-07, Vol.14 (1), p.15297-11, Article 15297

2024

Volltextzugriff (PDF)

Barriers to quality of life in patients with multiple sclerosis: a qualitative study

BMC neurology, 2022-05, Vol.22 (1), p.174-174, Article 174

2022

Volltextzugriff (PDF)

Detection of anti-NMDA receptor antibodies following BBIBP-CorV COVID-19 vaccination in a rituximab-treated person with multiple sclerosis presenting with manifestations of an acute relapse

Human vaccines & immunotherapeutics, 2022-12, Vol.18 (1), p.2033540-2033540

2022

Volltextzugriff (PDF)

The effect of counseling based on the PLISSIT model on sexual quality of life of married women with multiple sclerosis referring to MS center in 2019: a randomized, controlled trial

Archives of women's mental health, 2021-06, Vol.24 (3), p.437-444

2021

Volltextzugriff (PDF)

Rituximab-associated PRES in antibody-mediated kidney rejection: A case report

Transplant immunology, 2023-10, Vol.80, p.101907, Article 101907

2023

Volltextzugriff (PDF)

Evaluation of S100A12 and Apo-A1 plasma level potency in untreated new relapsing-remitting multiple sclerosis patients and their family members

Scientific reports, 2022-02, Vol.12 (1), p.2160-2160, Article 2160

2022

Volltextzugriff (PDF)

Acute relapse and poor immunization following COVID-19 vaccination in a rituximab-treated multiple sclerosis patient

Human vaccines & immunotherapeutics, 2021-10, Vol.17 (10), p.3481-3483

2021

Volltextzugriff (PDF)

miR-141 and miR-200a, Revelation of New Possible Players in Modulation of Th17/Treg Differentiation and Pathogenesis of Multiple Sclerosis

PloS one, 2015-05, Vol.10 (5), p.e0124555-e0124555

2015

Volltextzugriff (PDF)

Explaining the facilitators of quality of life in patients with multiple sclerosis: a qualitative study

BMC neurology, 2021-05, Vol.21 (1), p.193-193, Article 193

2021

Volltextzugriff (PDF)

A compound downregulation of SRRM2 and miR-27a-3p with upregulation of miR-27b-3p in PBMCs of Parkinson's patients is associated with the early stage onset of disease

PloS one, 2020-11, Vol.15 (11), p.e0240855-e0240855

2020

Volltextzugriff (PDF)

Incidence of anxiety in epilepsy during coronavirus disease (COVID-19) pandemic

Epilepsy & behavior, 2020-11, Vol.112, p.107442-107442, Article 107442

2020

Volltextzugriff (PDF)

N-Methyl-D-Aspartate (NMDA)-Type Glutamate Receptors and Demyelinating Disorders: A Neuroimmune Perspective

Mini reviews in medicinal chemistry, 2022-01, Vol.22 (20), p.2624-2640

2022

Volltextzugriff (PDF)

Dietary approach to stop hypertension (DASH), but not Mediterranean and MIND, dietary pattern protects against Parkinson's disease

Food science & nutrition, 2024-02, Vol.12 (2), p.943-951

2024

Volltextzugriff (PDF)

Can COVID‐19 accelerate neurodegeneration?

Clinical case reports, 2021-07, Vol.9 (7), p.n/a

2021

Volltextzugriff (PDF)

Autoimmune encephalitis: the first observational study from Iran

Neurological sciences, 2022-02, Vol.43 (2), p.1239-1248

2022

Volltextzugriff (PDF)

Patent foramen ovale leading to mismanagement in a mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke‐like episodes patient

Clinical case reports, 2023-07, Vol.11 (7), p.e7723-n/a

2023

Volltextzugriff (PDF)

Does COVID-19 increase the long-term relapsing-remitting multiple sclerosis clinical activity? A cohort study

BMC neurology, 2022-02, Vol.22 (1), p.64-64, Article 64

2022

Volltextzugriff (PDF)

Effect of Aquatic Exercise Training on Fatigue and Health-Related Quality of Life in Patients With Multiple Sclerosis

Archives of physical medicine and rehabilitation, 2012-10, Vol.93 (10), p.1701-1708

2012

Volltextzugriff (PDF)

Movement Disorders Associated with COVID-19

Parkinson's disease, 2021-11, Vol.2021, p.3227753-11

2021

Volltextzugriff (PDF)

Multiple sclerosis epidemiology in Asia and Oceania; A systematic review and meta-analysis

Multiple sclerosis and related disorders, 2021-09, Vol.54, p.103119-103119, Article 103119

2021

Volltextzugriff (PDF)

Decreased expression of Sema3A, an immune modulator, in blood sample of multiple sclerosis patients

Gene, 2017-04, Vol.610, p.59-63

2017

Volltextzugriff (PDF)

1 – 25 von 374

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(268)
Mit Volltextzugriff
(328)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Incidence of Anxiety in Parkinson's Disease During the Coronavirus Disease (COVID‐19) Pandemic

Significant modulations of linc001128 and linc0938 with miR-24-3p and miR-30c-5p in Parkinson disease

Immunomodulatory drug fingolimod (FTY720) restricts the growth of opportunistic yeast Candida albicans in vitro and in a mouse candidiasis model

Immunomodulatory drug fingolimod (FTY720) restricts the growth of opportunistic yeast Candida albicans in vitro and in a mouse candidiasis model

Span of spleen is associated with disability status in multiple sclerosis: a cross-sectional abdominopelvic ultrasonography study

Barriers to quality of life in patients with multiple sclerosis: a qualitative study

Detection of anti-NMDA receptor antibodies following BBIBP-CorV COVID-19 vaccination in a rituximab-treated person with multiple sclerosis presenting with manifestations of an acute relapse

The effect of counseling based on the PLISSIT model on sexual quality of life of married women with multiple sclerosis referring to MS center in 2019: a randomized, controlled trial

Rituximab-associated PRES in antibody-mediated kidney rejection: A case report

Evaluation of S100A12 and Apo-A1 plasma level potency in untreated new relapsing-remitting multiple sclerosis patients and their family members

Acute relapse and poor immunization following COVID-19 vaccination in a rituximab-treated multiple sclerosis patient

miR-141 and miR-200a, Revelation of New Possible Players in Modulation of Th17/Treg Differentiation and Pathogenesis of Multiple Sclerosis

Explaining the facilitators of quality of life in patients with multiple sclerosis: a qualitative study

A compound downregulation of SRRM2 and miR-27a-3p with upregulation of miR-27b-3p in PBMCs of Parkinson's patients is associated with the early stage onset of disease

Incidence of anxiety in epilepsy during coronavirus disease (COVID-19) pandemic

N-Methyl-D-Aspartate (NMDA)-Type Glutamate Receptors and Demyelinating Disorders: A Neuroimmune Perspective

Dietary approach to stop hypertension (DASH), but not Mediterranean and MIND, dietary pattern protects against Parkinson's disease

Can COVID‐19 accelerate neurodegeneration?

Autoimmune encephalitis: the first observational study from Iran

Patent foramen ovale leading to mismanagement in a mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke‐like episodes patient

Does COVID-19 increase the long-term relapsing-remitting multiple sclerosis clinical activity? A cohort study

Effect of Aquatic Exercise Training on Fatigue and Health-Related Quality of Life in Patients With Multiple Sclerosis

Movement Disorders Associated with COVID-19

Multiple sclerosis epidemiology in Asia and Oceania; A systematic review and meta-analysis

Decreased expression of Sema3A, an immune modulator, in blood sample of multiple sclerosis patients

Suchergebnisse filtern